for the German Chemo No Study Group. Randomized adjuvant therapy trial in high-risk lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator inhibitor type I - Jänicke, F; Prechtl, A; Thomssen, C (J Natl Cancer Inst, 2001)
et al.